Get started
Author

Aiwu Bian

Observed name: Ai-Wu Bian
Observed institution: East China Normal University
ORCID: 0000-0001-9223-627X
Observed ORCID: 0000-0001-9223-627X
OpenAlex ID: A5004493320
Targeting STAT3 by a small molecule suppresses pancreatic cancer progression
2021 · Huang Chen, Aiwu Bian, et al. · Oncogene · 82
PDF
Selectively Targeting STAT3 Using a Small Molecule Inhibitor is a Potential Therapeutic Strategy for Pancreatic Cancer
2022 · Huang Chen, Wenbo Zhou, et al. · Clinical Cancer Research · 47
PDF
Discovery of the Highly Selective and Potent STAT3 Inhibitor for Pancreatic Cancer Treatment
2024 · Huang Chen, Aiwu Bian, et al. · ACS Central Science · 41
Discovery of a Highly Potent and Orally Bioavailable STAT3 Dual Phosphorylation Inhibitor for Pancreatic Cancer Treatment
2022 · Peng He, Aiwu Bian, et al. · Journal of Medicinal Chemistry · 32
Synthesis and anticancer activity of novel 9,13-disubstituted berberine derivatives
2019 · Zhi-Cheng Wang, Jing Wang, et al. · Bioorganic & Medicinal Chemistry Letters · 30
Discovery of a Novel Potent STAT3 Inhibitor HP590 with Dual p-Tyr705/Ser727 Inhibitory Activity for Gastric Cancer Treatment
2022 · Peng He, Ying Miao, et al. · Journal of Medicinal Chemistry · 26
A novel small-molecule activator of unfolded protein response suppresses castration-resistant prostate cancer growth
2022 · Huang Chen, Ying Miao, et al. · Cancer Letters · 14
WB518, a novel STAT3 inhibitor, effectively alleviates IMQ and TPA-induced animal psoriasis by inhibiting STAT3 phosphorylation and Keratin 17
2023 · Chaowen Ti, Huang Chen, et al. · International Immunopharmacology · 10
Determining the Drug-Like Properties of Ailanthone, a Novel Chinese Medicine Monomer with Anti-CRPC Activity
2020 · Pan Hu, Dandan Guo, et al. · Planta Medica · 4
Correction: Targeting STAT3 by a small molecule suppresses pancreatic cancer progression
2024 · Huang Chen, Aiwu Bian, et al. · Oncogene · 1
Supplementary Figures S1-S13 from Selectively Targeting STAT3 Using a Small Molecule Inhibitor is a Potential Therapeutic Strategy for Pancreatic Cancer
2025 · Huang Chen, Wenbo Zhou, et al.
PDF
Supplementary Methods from Selectively Targeting STAT3 Using a Small Molecule Inhibitor is a Potential Therapeutic Strategy for Pancreatic Cancer
2025 · Huang Chen, Wenbo Zhou, et al.
PDF
Supplementary Tables S1-S6 from Selectively Targeting STAT3 Using a Small Molecule Inhibitor is a Potential Therapeutic Strategy for Pancreatic Cancer
2025 · Huang Chen, Wenbo Zhou, et al.
PDF
Supplementary Tables S1-S6 from Selectively Targeting STAT3 Using a Small Molecule Inhibitor is a Potential Therapeutic Strategy for Pancreatic Cancer
2023 · Huang Chen, Wenbo Zhou, et al.
Supplementary Methods from Selectively Targeting STAT3 Using a Small Molecule Inhibitor is a Potential Therapeutic Strategy for Pancreatic Cancer
2023 · Huang Chen, Wenbo Zhou, et al.
PDF
Supplementary Figures S1-S13 from Selectively Targeting STAT3 Using a Small Molecule Inhibitor is a Potential Therapeutic Strategy for Pancreatic Cancer
2023 · Huang Chen, Wenbo Zhou, et al.
Supplementary Tables S1-S6 from Selectively Targeting STAT3 Using a Small Molecule Inhibitor is a Potential Therapeutic Strategy for Pancreatic Cancer
2023 · Huang Chen, Wenbo Zhou, et al.
PDF
Supplementary Figures S1-S13 from Selectively Targeting STAT3 Using a Small Molecule Inhibitor is a Potential Therapeutic Strategy for Pancreatic Cancer
2023 · Huang Chen, Wenbo Zhou, et al.
PDF
Supplementary Methods from Selectively Targeting STAT3 Using a Small Molecule Inhibitor is a Potential Therapeutic Strategy for Pancreatic Cancer
2023 · Huang Chen, Wenbo Zhou, et al.
Data from Selectively Targeting STAT3 Using a Small Molecule Inhibitor is a Potential Therapeutic Strategy for Pancreatic Cancer
2023 · Huang Chen, Wenbo Zhou, et al.
Data from Selectively Targeting STAT3 Using a Small Molecule Inhibitor is a Potential Therapeutic Strategy for Pancreatic Cancer
2023 · Huang Chen, Wenbo Zhou, et al.
Works count: 21
Citation count: 287
H-index: 8
I10-index: 8
Year
Topic
Type